|
OMIM |
Link |
Information gain |
01 |
|
kala-azar, susceptibility to, 1
|
[NCBI]
|
0.00146904
|
|
|
hepatitis c virus, susceptibility to
|
[NCBI]
|
0.000230707
|
|
|
malaria, susceptibility to
|
[NCBI]
|
0.000210256
|
|
|
CMAH
|
[NCBI]
|
0.000123712
|
|
|
leprosy, susceptibility to
|
[NCBI]
|
0.00010764
|
|
|
sickle cell anemia
|
[NCBI]
|
8.35215e-05
|
|
|
FY
|
[NCBI]
|
5.47089e-05
|
|
|
source of immunodominant major histocompatibility complex-associated peptides
|
[NCBI]
|
4.29377e-05
|
|
|
GARP
|
[NCBI]
|
4.29377e-05
|
|
|
PPIA
|
[NCBI]
|
4.18183e-05
|
|
|
RPS20
|
[NCBI]
|
3.63031e-05
|
|
|
FGD4
|
[NCBI]
|
3.41111e-05
|
|
|
S100A12
|
[NCBI]
|
3.41111e-05
|
|
|
OGFR
|
[NCBI]
|
3.32594e-05
|
|
|
IRGM
|
[NCBI]
|
3.32594e-05
|
|
|
Ss
|
[NCBI]
|
3.18535e-05
|
|
|
G6PD
|
[NCBI]
|
2.9718e-05
|
|
|
APOBEC3G
|
[NCBI]
|
2.82257e-05
|
|
|
RPS6KA5
|
[NCBI]
|
2.64779e-05
|
|
|
MN
|
[NCBI]
|
2.43791e-05
|
|
|
ICAM1
|
[NCBI]
|
2.38721e-05
|
|
|
A2M
|
[NCBI]
|
2.11908e-05
|
|
|
SLC11A1
|
[NCBI]
|
2.0795e-05
|
|
|
TNF
|
[NCBI]
|
2.04791e-05
|
|
|
AQP1
|
[NCBI]
|
1.87926e-05
|
|
|
IL4
|
[NCBI]
|
1.78001e-05
|
|
|
STAT1
|
[NCBI]
|
1.56054e-05
|
|
|
AGER
|
[NCBI]
|
1.56054e-05
|
|
|
VASP
|
[NCBI]
|
1.53777e-05
|
|
|
ACHE
|
[NCBI]
|
1.35476e-05
|
|
|
EGF
|
[NCBI]
|
1.11464e-05
|
|
|
CAT
|
[NCBI]
|
1.09448e-05
|
|
|
MB
|
[NCBI]
|
9.38031e-06
|
|
|
TLR4
|
[NCBI]
|
8.32274e-06
|
|
|
VIP
|
[NCBI]
|
7.49965e-06
|
|
|
RNASE3
|
[NCBI]
|
6.60197e-06
|
|
|
GAPDH
|
[NCBI]
|
6.16482e-06
|
|
|
NPY
|
[NCBI]
|
3.94058e-06
|
|
|
CF
|
[NCBI]
|
1.20958e-06
|
|
|
VEGF
|
[NCBI]
|
1.06699e-06
|
|
|
KLK3
|
[NCBI]
|
3.74512e-07
|
|
|
SLE
|
[NCBI]
|
1.07801e-07
|
|
|
NGFB
|
[NCBI]
|
1.94163e-09
|
|